Skip to main content

SHB 1066

In Committee

House

Regulated substance use data

Creating a data dashboard to track use of regulated substances.

This status may be delayed. See Action History below for the latest updates.

How does a bill become law?
  1. Introduced: The bill is filed and assigned a number.
  2. Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
  3. Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
  4. Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
  5. Governor: The Governor reviews the bill and decides whether to sign or veto it.
  6. Signed: The bill has been signed into law.
Introduced: January 28, 2025
Last Action: March 12, 2026
Status: H Rules 3C

AI Analysis

This analysis was generated by AI and may contain errors. It is not legal advice. Always refer to the official bill text for authoritative information.
People & CommunitiesPeople-leaningCorporate & Wealthy Interests

This bill requires the Washington State Liquor and Cannabis Board to create and maintain a public data dashboard that tracks enforcement, funding, health outcomes, and economic impacts related to regulated substances like alcohol, cannabis, tobacco, and vapor products. It aims to increase transparency and support informed public health decision-making.

  • Create a public data dashboard on the Washington State Liquor and Cannabis Board’s website to track policies, funding, and health outcomes related to regulated substances (e.g., alcohol, cannabis, tobacco, vapor products).
  • Require the board to publish annual compliance and enforcement data, including redacted numbers of citations for selling regulated substances to people under 21 years old and for selling to intoxicated persons.
  • Include youth substance use data from the Healthy Youth Survey and state health agencies on prevalence, access, and perceptions of regulated substances.
  • Require reporting on funding for prevention and treatment programs, including amounts from the Department of Health and Health Care Authority, and compare tobacco prevention funding to CDC recommendations.
  • Require reporting on health and economic impacts, including annual health care costs, Medicaid spending, deaths linked to substance use, and health equity disparities.
  • Require reporting on taxes, fees, and penalties collected from regulated substances and data on cannabis market inversion and diversion (i.e., illegal movement of cannabis into or out of the regulated market).
  • Require annual updates to the dashboard, with personally identifiable information redacted from all enforcement data.

Who is affected

  • Liquor, cannabis, tobacco, and vapor product retailers and licenseesBusinesses that sell regulated substances (e.g., liquor, cannabis, tobacco, vapor products) will be affected because the bill requires public reporting of enforcement data—including citations and compliance rates—that may influence public perception and regulatory scrutiny of their operations.
  • State agencies (e.g., Department of Health, Health Care Authority, Liquor and Cannabis Board)State and local agencies involved in public health, substance use prevention, and enforcement (e.g., Department of Health, Health Care Authority, Washington State Liquor and Cannabis Board) will need to share data and coordinate to produce the required dashboard.
  • Families, educators, and community advocatesFamilies, educators, and community organizations may use the dashboard to better understand youth substance use trends and access to prevention resources in their communities.
  • Washington residents (especially youth and young adults)Residents—especially youth and young adults—may benefit from increased transparency about how substance use is monitored and prevented, and how public funds are used for prevention and treatment.
Effective: July 28, 2025Fiscal impact: The bill does not specify new funding or cost to the state; it requires existing agencies to use current staff and resources to compile and publish data, so any fiscal impact is expected to be minimal or absorbed within existing budgets.
Model: Intel/Qwen3-Coder-Next-int4-AutoRoundGenerated: Mar 19, 2026 at 6:29 PM

Pro/Con Analysis

Stronger case for benefits

Potential Benefits (5)
  • Public access to youth substance use data, prevention funding levels, and health equity metrics will empower community organizations, schools, and families to advocate for evidence-based interventions and hold agencies accountable for equitable resource allocation.

    Public SafetyPeopleRef: Sec. 1(2)(d)-(e), (f), (g)
  • Transparent reporting of taxes, fees, and penalties collected from regulated substances enables the public to assess whether revenue aligns with public health goals and whether fees disproportionately burden small businesses or consumers.

    FinancialPeopleRef: Sec. 1(2)(h)(i)-(iii)
  • Comparing state tobacco prevention funding to CDC recommendations will highlight underfunding gaps, supporting advocacy for increased public health investment—especially beneficial for communities with high smoking rates and limited access to cessation programs.

    HealthcarePeopleRef: Sec. 1(2)(g)(v)
  • Mandated reporting of health equity and demographic disparities in substance use and related harms will help identify and address racial, geographic, and socioeconomic inequities—critical for communities disproportionately affected by substance-related health outcomes.

    HealthcarePeopleRef: Sec. 1(2)(g)(vi)-(vii)
  • Public disclosure of enforcement data (e.g., citations for sales to minors or intoxicated persons) increases accountability for retailers and may incentivize better compliance, indirectly enhancing community safety—especially in neighborhoods with high density of alcohol/tobacco outlets.

    Public SafetyPeopleRef: Sec. 1(2)(a)-(c)
Potential Concerns (3)
  • The requirement to redact personally identifiable information from enforcement data (e.g., citations, compliance rates) may reduce the utility of the data for local law enforcement and licensing authorities seeking to identify repeat or high-risk violators, potentially limiting targeted enforcement capacity.

    Local GovernmentRef: Sec. 1(2)(a)-(c)
  • While penalties collected from licensees are reported, the bill does not require analysis of whether penalty enforcement disproportionately impacts small retailers (e.g., mom-and-pop liquor stores, small cannabis shops) compared to large chains, potentially masking regressive enforcement patterns.

    Business & EmploymentRef: Sec. 1(2)(h)(iii)
  • Reporting on cannabis market inversion and diversion may increase regulatory scrutiny of licensed operators, potentially deterring small-scale participation in the legal market or increasing compliance costs for micro-businesses that lack legal expertise.

    Business & EmploymentRef: Sec. 1(2)(i)

Who Is Most Affected

Families, educators, and community advocatesPositive Impact

Families and community advocates gain access to data on youth substance use trends and prevention funding, enabling more informed advocacy and local action—especially in underserved communities where data gaps have historically hindered intervention.

State agencies (e.g., Department of Health, Health Care Authority, Liquor and Cannabis Board)Mixed Impact

State and local agencies (e.g., DOH, HCA, LCB) must coordinate data sharing and reporting, which may strain existing resources but also improve interagency collaboration and data infrastructure—benefiting long-term public health planning.

Liquor, cannabis, tobacco, and vapor product retailers and licenseesMixed Impact

Retailers (especially small, independent liquor, tobacco, and cannabis shops) face increased transparency of enforcement actions, which could improve public trust but may also expose them to reputational risk or heightened scrutiny without proportional support for compliance.

Washington residents (especially youth and young adults)Positive Impact

Youth and young adults benefit indirectly through improved prevention programs and more accurate public understanding of substance use risks—though the bill does not directly change access or behavior.